ClinicalTrials.gg
Drug

Ibritumomab tiuxetan clinical trials

Also written Zevalin and IDEC-Y2B8.

studies test it
45
open now
0
in phase 3
8
first study started
2001

How each study uses ibritumomab tiuxetan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
19 Feb 2002 · ZEVALIN · BLA 125019 (FDA, Drugs@FDA)
European Union
16 Jan 2004 · Zevalin · EMEA/H/C/000547 (EMA; now lapsed)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Ibritumomab Tiuxetan
15
Ibritumomab Tiuxetan (Zevalin)
5
Ibritumomab
3
Rituximab (Mabthera)
2
90Y-ibritumomab tiuxetan (Zevalin)
2

Brand

Zevalin
19

Development codes

IDEC-Y2B8
5

Studies by the year they started

43 studies that test it; most in 2006 (9)

Studies that test ibritumomab tiuxetan, by start year
YearStudies
20012
20022
20032
20044
20056
20069
20079
20084
20123
20132

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
34
Phase 3
8
Phase 4
1
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 8 · Other 37

M.D. Anderson Cancer Center (7) · Biogen (2) · Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea (2) · Bayer (2) · Spectrum Pharmaceuticals, Inc (2) · Fondazione Italiana Linfomi - ETS (1) · SWOG Cancer Research Network (1) · Sheba Medical Center (1)

Often tested with

Tested in the same studies.

Rituximab (10) · Fludarabine (2) · Mitoxantrone (2) · Yttrium Y-90 ibritumomab tiuxetan (2) · Bortezomib (2) · Patient Observation (1) · Maintenance Therapy (1) · Dexamethasone (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses ibritumomab tiuxetan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 45

See all 45 studies that test ibritumomab tiuxetan →

Given beside what is tested · 3 — ibritumomab tiuxetan is usual care or a partner of the new treatment

Codes

What other systems call ibritumomab tiuxetan · ClinicalTrials.gg INT004320

  • MeSH (NLM) C422802ibritumomab tiuxetanOne source NLM
  • UNII (FDA) 4Q52C550XKIBRITUMOMAB TIUXETANConfirmed FDA, NLM, Wikidata
  • RxNorm 262323Confirmed FDA, Wikidata
  • Wikidata Q635415ibritumomabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C29981Ibritumomab TiuxetanConfirmed FDA, Wikidata
  • DrugBank DB00078One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.